• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Internet Res. Referencing the novel coronavirus as the "Chinese virus" or "China virus" on Twitter: COVID-19 stigma

tetano

Editor, Senior Moderator
J Med Internet Res. 2020 Apr 26. doi: 10.2196/19301. [Epub ahead of print]
Referencing the novel coronavirus as the "Chinese virus" or "China virus" on Twitter: COVID-19 stigma.


Budhwani H[SUP]1[/SUP], Sun R[SUP]1[/SUP].

Author information




Abstract

BACKGROUND:

Stigma is the deleterious, structural force that devalues members of groups that hold undesirable characteristics. Since, stigma is created and reinforced by society -- through in-person and online social interactions -- referencing the novel coronavirus as the "Chinese virus" or "China virus" has the potential to create and perpetuate stigma.
OBJECTIVE:

Our objective was to assess if there was an increase in the frequency of the phrases "Chinese virus" and "China virus" on Twitter, post- the March 16, 2020 United States presidential reference of this term.
METHODS:

Using the Sysomos software, we extracted tweets from the United States using a list of keywords that were derivatives of "Chinese virus." We compared tweets at the national and state levels posted between March 9th and March 15th (pre-period) with those posted between March 19th and March 25th (post-period). We used Stata 16 for quantitative analysis and Python to plot a state-level heat map.
RESULTS:

A total of 16,535 "Chinese virus" or "China virus" tweets were identified in the pre-period and 177,327 of these tweets were identified in the post-period, illustrating an increase of nearly ten times at the national level. All fifty states witnessed an increase in the number of tweets exclusively mentioning "Chinese virus" or "China virus" instead of COVID-19 or coronavirus. On average, 0.38 tweets referencing "Chinese virus" or "China virus" were posted per 10,000 population at the state level in the pre-period, and 4.08 of these stigmatizing tweets were posted in the post-period, also indicating a ten fold increase. The five states with highest number of post-period "Chinese virus" tweets were: Pennsylvania (5,249), New York (11,754), Florida (13,070), Texas (14,861), and California (19,442). Adjusting for population size, the five states with the highest prevalence of post-period "Chinese virus" tweets were: Arizona (5.85), New York (6.04), Florida (6.09), Nevada (7.72), and Wyoming (8.76). The five states with the largest increase in pre- to post-period "Chinese virus" tweets were: Kansas (1,202%), South Dakota (1,233%), Mississippi (1,387%), New Hampshire (1,420%), and Idaho (1,457%).
CONCLUSIONS:

The rise in tweets referencing "Chinese virus" or "China virus," along with the content of these tweets, indicate that 1) knowledge translation may be occurring online and that 2) COVID-19 stigma is likely being perpetuated on Twitter.
CLINICALTRIAL:




PMID:32343669DOI:10.2196/19301
Free full text
 
Back
Top Bottom